IndexIQ Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,051
Closed -$395K 1549
2021
Q4
$395K Sell
7,051
-456
-6% -$27.9K 0.01% 790
2021
Q3
$489K Buy
7,507
+752
+11% +$51.3K 0.02% 572
2021
Q2
$428K Sell
6,755
-207
-3% -$12.2K 0.01% 595
2021
Q1
$417K Sell
6,962
-1,281
-16% -$69.7K 0.01% 470
2020
Q4
$411K Buy
8,243
+851
+12% +$40K 0.02% 474
2020
Q3
$377K Buy
7,392
+401
+6% +$16.7K 0.02% 339
2020
Q2
$245K Sell
6,991
-883
-11% -$30.4K 0.01% 415
2020
Q1
$200K Buy
+7,874
New +$234K 0.01% 305

Other funds holding AXNX

IndexIQ Advisors's AXNX Position: Q1 2022 in Review

IndexIQ Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2022, closing a stake of 7,051 shares — an estimated $395K sold.

IndexIQ Advisors first reported a position in AXNX in Q1 2020 and held it in 8 quarters. The position peaked at $489K in Q3 2021. 186 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

  • IndexIQ Advisors reported no remaining Axonics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 7,051 Axonics, Inc. Common Stock shares in Q1 2022, an estimated $395K.
  • IndexIQ Advisors first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
  • IndexIQ Advisors's Axonics, Inc. Common Stock position peaked at $489K in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.